glp 1 death rate A landmark study published in The BMJ followed 600,000+ US veterans GLP-1 receptor agonists and risk

Better erectile function

Antioxidant pathway influence: Some research indicates potential modulation of antioxidant defense systems, contributing to cellular protection in oxidative stress models

Targeting HDACs with HDACi might have potential for treatment of neurological disorders such as Huntington's disease, Alzheimer's disease, amyotrophic lateral sclerosis, seizure disorders, spinal muscular atrophy, Rett syndrome, stroke, Fragile X syndrome, and Rubinstein-Taybi syndrome (Chuang et al., 2009)

Side effects tend to be more common and intense in the first weeks of taking a semaglutide or other GLP-1, but nausea can last for several weeks up to a few months